Opportunities for quality improvement in cystic fibrosis newborn screening

被引:10
作者
Groose, Molly K. [1 ,2 ]
Reynolds, Richard [3 ]
Li, Zhanhai [4 ]
Farrell, Philip M. [1 ,2 ]
机构
[1] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pediat, Madison, WI 53726 USA
[2] Univ Wisconsin, Sch Med & Publ Hlth, Dept Populat Hlth Sci, Madison, WI 53726 USA
[3] Reynolds Management Serv, Middleton, WI 53562 USA
[4] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biostat & Med Informat, Madison, WI 53726 USA
关键词
Cystic fibrosis; Quality improvement; Newborn screening; Communication; Risk; PFMEA;
D O I
10.1016/j.jcf.2010.04.001
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: With the rapid implementation of cystic fibrosis (CF) newborn screening (NBS), quality improvement (QI) has become essential to identify and prevent errors. Using Process Failure Modes and Effects Analysis (PFMEA), we adapted this method to determine if it could be applied to discover and rank high priority QI opportunities. Methods: Site visits to three programmes were conducted, and PFMEA exercises were accomplished in Colorado, Massachusetts and Wisconsin with 23 experienced professionals. During each of these comprehensive sessions, participants identified and ranked potential failures based on severity, occurrence and detection to calculate risk priority number (RPN) values. Results: A total of 96 failure modes were generated and ranked in a list of the 20 riskiest problems that show no significant discordances by site, although there were differences by profession of the rater, particularly nurses. Conclusions: Our results illustrate that the PFMEA method applies well to CF NBS and that steps requiring communication and information transfer are perceived to be the highest risks. The number of identified failures makes and their potential impact demonstrate considerable overall risk and a need for ongoing QI. (C) 2010 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:284 / 287
页数:4
相关论文
共 12 条
[1]  
[Anonymous], C34A3 CLSI
[2]   Newborn screening for cystic fibrosis: An opportunity to improve care and outcomes [J].
Campbell, PW ;
White, TB .
JOURNAL OF PEDIATRICS, 2005, 147 (03) :S2-S5
[3]   European best practice guidelines for cystic fibrosis neonatal screening [J].
Castellani, Carlo ;
Southern, Kevin W. ;
Brownlee, Keith ;
Roelse, Jeannette Dankert ;
Duff, Alistair ;
Farrell, Michael ;
Mehta, Anil ;
Munck, Anne ;
Pollitt, Rodney ;
Sermet-Gaudelus, Isabelle ;
Wilcken, Bridget ;
Ballmann, Manfred ;
Corbetta, Carlo ;
de Monestrol, Isabelle ;
Farrell, Philip ;
Feilcke, Maria ;
Ferec, Claude ;
Gartner, Silvia ;
Gaskin, Kevin ;
Hammermann, Jutta ;
Kashirskaya, Nataliya ;
Loeber, Gerard ;
Macek, Milan, Jr. ;
Mehta, Gita ;
Reiman, Andreas ;
Rizzotti, Paolo ;
Sammon, Alec ;
Sands, Dorota ;
Smyth, Alan ;
Sommerburg, Olaf ;
Torresani, Toni ;
Travert, Georges ;
Vernooij, Annette ;
Elborn, Stuart .
JOURNAL OF CYSTIC FIBROSIS, 2009, 8 (03) :153-173
[4]  
*CLIN LAB STAND I, 2009, ILA31P CLSI
[5]   Guidelines for implementation of cystic fibrosis newborn screening programs: Cystic Fibrosis Foundation workshop report [J].
Comeau, Anne Marie ;
Accurso, Frank J. ;
White, Terry B. ;
Campbell, Preston W., III ;
Hoffman, Gary ;
Parad, Richard B. ;
Wilfond, Benjamin S. ;
Rosenfeld, Margaret ;
Sontag, Marci K. ;
Massie, John ;
Farrell, Philip M. ;
O'Sullivan, Brian P. .
PEDIATRICS, 2007, 119 (02) :E495-E518
[6]   Assessment of parental understanding by pediatric residents during Counseling after newborn genetic screening [J].
Farrell, Michael H. ;
Kuruvilla, Pramita .
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2008, 162 (03) :199-204
[7]  
Farrell P M, 2000, Adv Pediatr, V47, P79
[8]  
GROSSE SD, 2004, MMWR-MORBID MORTAL W, V55, P1
[9]  
McDermott R., 1996, The basics of FMEA
[10]  
O'Leary D. S., 2002, REDUCING MED ERRORS